SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Alexander Denis Professor) ;hsvcat:1"

Sökning: WFRF:(Alexander Denis Professor) > Naturvetenskap

  • Resultat 1-2 av 2
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Bin Kaderi, Mohamed Arifin, 1978- (författare)
  • Assessment of Novel Molecular Prognostic Markers in Chronic Lymphocytic Leukemia
  • 2010
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • The clinical course of chronic lymphocytic leukemia (CLL) is highly heterogeneous, which has prompted the search for biomarkers that can predict prognosis in this disease. The IGHV gene mutation status and certain genomic aberrations have been identified as reliable prognostic markers of clinical outcome for this disorder. However, the search for more feasible prognostic markers in CLL is still being pursued. Recently, certain single nucleotide polymorphisms (SNPs) in the GNAS1, BCL2 and MDM2 genes and the RNA expression levels of the LPL, ZAP70, TCL1, CLLU1 and MCL1 genes were suggested as novel prognostic markers in CLL. In papers I-III, we performed genotyping analyses of the GNAS1 T393C, BCL2 -938C>A and MDM2 SNP309 polymorphisms in 268-418 CLL patients and related the genotypes with clinical data. Association studies between the polymorphisms and established prognostic markers (i.e. IGHV mutation status, genomic aberrations, CD38 expression) were also performed. Our studies did not find any significant relationship between these SNPs with either clinical outcome or other known prognostic markers in CLL. In paper IV, we measured the RNA expression levels of LPL, ZAP70, TCL1, CLLU1 and MCL1 in 252 CLL cases and correlated these levels with clinical outcome. Here, we verified that high expression of all these RNA-based markers, except MCL1, were associated with an unfavourable prognosis. We also confirmed a close relationship between IGHV mutation status and the RNA-based markers, especially for LPL and CLLU1 expression. Among the RNA-based markers, multivariate analysis revealed LPL expression as the strongest independent prognostic marker for overall survival and time to treatment. Furthermore, the RNA-based markers could add further prognostic information to established markers in subgroups of patients, with LPL expression status giving the most significant results. In summary, data from papers I-III could not verify the GNAS1 T393C, BCL2 -938C>A and MDM2 SNP309 polymorphisms as prognostic markers in CLL. Future SNP markers must hence be confirmed in large, independent cohorts before being proposed as prognostic marker in CLL. In paper IV, we conclude that LPL expression appears to be the strongest among the RNA-based markers for CLL prognostication. Further efforts to standardize LPL quantification are required before it can be applied in the clinical laboratory to predict clinical outcome in this disease.
  •  
2.
  • Evangelou, Evangelos, et al. (författare)
  • Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.
  • 2018
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 50:10, s. 1412-1425
  • Tidskriftsartikel (refereegranskat)abstract
    • High blood pressure is a highly heritable and modifiable risk factor for cardiovascular disease. We report the largest genetic association study of blood pressure traits (systolic, diastolic and pulse pressure) to date in over 1 million people of European ancestry. We identify 535 novel blood pressure loci that not only offer new biological insights into blood pressure regulation but also highlight shared genetic architecture between blood pressure and lifestyle exposures. Our findings identify new biological pathways for blood pressure regulation with potential for improved cardiovascular disease prevention in the future.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-2 av 2
Typ av publikation
tidskriftsartikel (1)
doktorsavhandling (1)
Typ av innehåll
övrigt vetenskapligt/konstnärligt (1)
refereegranskat (1)
Författare/redaktör
Gyllensten, Ulf B. (1)
Khaw, Kay-Tee (1)
Salomaa, Veikko (1)
Jula, Antti (1)
Perola, Markus (1)
Lind, Lars (1)
visa fler...
Raitakari, Olli T (1)
Melander, Olle (1)
Campbell, Harry (1)
Rudan, Igor (1)
Strachan, David P (1)
Evangelou, Marina (1)
Dimou, Niki (1)
Wareham, Nicholas J. (1)
Johansson, Åsa (1)
Almgren, Peter (1)
Laakso, Markku (1)
Ridker, Paul M. (1)
Chasman, Daniel I. (1)
Amin, Najaf (1)
van Duijn, Cornelia ... (1)
Sundström, Johan, Pr ... (1)
Rose, Lynda M (1)
Langenberg, Claudia (1)
Paré, Guillaume (1)
Boehnke, Michael (1)
Hamsten, Anders (1)
Scott, Robert A (1)
Shah, Nabi (1)
Gaziano, J Michael (1)
Havulinna, Aki S. (1)
Ripatti, Samuli (1)
Kähönen, Mika (1)
Lehtimäki, Terho (1)
Enroth, Stefan, 1976 ... (1)
Tuomilehto, Jaakko (1)
Verweij, Niek (1)
Rotter, Jerome I. (1)
Koskinen, Seppo (1)
Nelson, Christopher ... (1)
Mangino, Massimo (1)
Willemsen, Gonneke (1)
Oostra, Ben A. (1)
Gieger, Christian (1)
Peters, Annette (1)
Boomsma, Dorret I. (1)
Spector, Tim D. (1)
Samani, Nilesh J. (1)
Jarvelin, Marjo-Riit ... (1)
Sun, Yan V. (1)
visa färre...
Lärosäte
Uppsala universitet (2)
Stockholms universitet (1)
Lunds universitet (1)
Karolinska Institutet (1)
Språk
Engelska (2)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (2)Ta bort avgränsningen
Medicin och hälsovetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy